Simavita Updates on New Agreements, Pilots and Key Appointments
23 March 2015 - 8:00PM
Business Wire
Simavita Limited (ASX:SVA)(TSX-V:SV)(“Simavita” or the
“Company”), a global leader in the digital healthcare sector, is
pleased to provide details of material of new agreements to supply
its Smart Incontinence Management solution (SIM®) in Australia,
updates on the progress of showcase sites in Canada and Sweden and
the launch of significant pilot sites in the US, as well as
announce two key executive appointments.
Highlights from a more detailed announcement are below.
Simavita expands the roll out of its transformational Smart
Incontinence Management (SIM®) platform and executes further
agreements with leading aged care providers
New agreements have been signed with key customers in Australia
with McKenzie Group and Queensland Rehabilitation Services, and the
roll out of SIM® into Australian customer, Arcare’s facilities is
progressing, with 19 of 24 homes now using SIM®. It is anticipated
that the minimum aggregate value of the agreements with the above
customers will be around $800,000 AUD per annum.
"The importance of these groups to Simavita goes beyond a
commercial arrangement. Each one is recognised as a leading aged
care provider who is focused on the efficiencies and potential
revenue uplift gained from implementing cutting edge technologies
like SIM®. We are delighted to be working together," said Philippa
Lewis, CEO of Simavita.
Revenue is now being generated from the sale of SIM® on three
continents, with significant pilot programs proceeding well in the
US, Denmark, Canada and Sweden
In the US, Canada and Sweden, several aged care facilities are
piloting the SIM® technology. Importantly, the Swedish pilot
follows the earlier announcement that Simavita had signed Danish
distributor, Abena A/S after completion of a successful trial in
Denmark. Through a combination of direct sales and distribution
agreements with Medline in the US and Abena in Denmark, revenues
are now being realised in each of the key regions of Australia, the
United States and Europe.
Key executive appointments made to drive sales in Australian
and North American markets to drive SIM® sales
Simavita welcomes new key executives to the team.
Christopher Southerland joins Simavita as US Executive V.P. of
Sales and Marketing responsible for overseeing SIM® sales and
distribution activities in North America. Charles Cornish joins
Simavita in the role of Director ANZ. Charles will lead the
Company's Marketing, Sales and Service Team.
The full announcement can be accessed
via:http://sva.live.irmau.com/IRM/Company/ShowPage.aspx/PDFs/1031-10000000/Simavitaprogressupdate
For further information, see our website (www.simavita.com) or
contact the persons outlined below.
About Simavita
Simavita is a medical device company operating in the digital
healthcare sector that has developed an innovative, world first
solution for the management of urinary incontinence, with a focus
on the elderly. The first product is the SIM™ platform technology
which is an instrumented incontinence assessment application that
provides evidence based incontinence management care plans to the
residential aged care market.
About SIM™
SIM™ is a wireless sensor technology that delivers
evidence-based instrument incontinence data on individuals. SIM™
provides user friendly tools and software to assess the
incontinence condition and to help plan better outcomes. SIM™ is
used to detect, record and report incontinence events during a
compulsory or recommended assessment period in residential aged
care facilities to develop an evidence-based incontinence care
plan.
Conducting assessments is mandatory in many countries and the
incontinence assessment creates an influential element of care of
each individual.
CompanySimavita LimitedPhilippa Lewis,
+61-2-8405-6381Chief Executive OfficerThomas Howitt,
+61-418-351-127Chief Financial OfficerMedia and Investor
RelationsJane Lowe,
+61-411-117-774jane.lowe@irdepartment.com.au
Simavita (ASX:SVA)
Historical Stock Chart
From Sep 2024 to Oct 2024
Simavita (ASX:SVA)
Historical Stock Chart
From Oct 2023 to Oct 2024